Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized t...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2016-05, Vol.114, p.244-256 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 256 |
---|---|
container_issue | |
container_start_page | 244 |
container_title | European journal of medicinal chemistry |
container_volume | 114 |
creator | Zhou, Xue-Quan Li, Yang Zhang, Dong-Yan Nie, Yan Li, Zong-Jin Gu, Wen Liu, Xin Tian, Jin-Lei Yan, Shi-Ping |
description | Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively.
Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted]
•Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. |
doi_str_mv | 10.1016/j.ejmech.2016.02.055 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780511737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523416301453</els_id><sourcerecordid>1780511737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</originalsourceid><addsrcrecordid>eNp9UU1v1DAQtRCILoV_gJCPHEhqO4kTc0DaLp9SBYfC2ZrYk61XSRzs7Kr7I_jPddi2x56eZvzePM88Qt5ylnPG5cUux92A5iYXqcqZyFlVPSMrXssmK0RVPicrJkSRVaIoz8irGHeMsUoy9pKcCalUKZVYkX8bP00YqPHD1OMtRtpCREv9SM2NC9DT64Rdly1t2rstjDZ-pJ9_ri8ur9e0daN145ZC63o3Hz8sD9T0CAfYIgUzu8P_tjnOfva3zqSKphF0-TmMLg7UdxQmP80-uviavOigj_jmHs_Jn69ffm--Z1e_vv3YrK8yU0gxZ4pVXKhKYo2qbpSyCA3UgI0obWfalisBCowQlpfAGptQKtk0PClEEhbn5P1p7hT83z3GWQ8uGux7GNHvo-Z1kyx4XdSJWp6oJvgYA3Z6Cm6AcNSc6SUIvdOnIPQShGZCpyCS7N29w74d0D6KHi6fCJ9OBEx7HhwGHY3D0aB1Ac2srXdPO9wB5mOcBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780511737</pqid></control><display><type>article</type><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</creator><creatorcontrib>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</creatorcontrib><description>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively.
Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted]
•Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2016.02.055</identifier><identifier>PMID: 26994692</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Anticancer ability ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis mechanism ; Binding Sites - drug effects ; Cattle ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Chirality ; Copper - chemistry ; Copper - pharmacology ; Copper complexes ; Crystal structure ; Crystallography, X-Ray ; DNA - chemistry ; DNA Cleavage ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Humans ; Ligands ; Models, Molecular ; Molecular Structure ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Schiff Bases - chemical synthesis ; Schiff Bases - chemistry ; Schiff Bases - pharmacology ; Serum Albumin, Bovine - chemistry ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2016-05, Vol.114, p.244-256</ispartof><rights>2016 Elsevier Masson SAS</rights><rights>Copyright © 2016 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</citedby><cites>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2016.02.055$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26994692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xue-Quan</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Zhang, Dong-Yan</creatorcontrib><creatorcontrib>Nie, Yan</creatorcontrib><creatorcontrib>Li, Zong-Jin</creatorcontrib><creatorcontrib>Gu, Wen</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Tian, Jin-Lei</creatorcontrib><creatorcontrib>Yan, Shi-Ping</creatorcontrib><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively.
Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted]
•Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</description><subject>Animals</subject><subject>Anticancer ability</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis mechanism</subject><subject>Binding Sites - drug effects</subject><subject>Cattle</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Chirality</subject><subject>Copper - chemistry</subject><subject>Copper - pharmacology</subject><subject>Copper complexes</subject><subject>Crystal structure</subject><subject>Crystallography, X-Ray</subject><subject>DNA - chemistry</subject><subject>DNA Cleavage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Schiff Bases - chemical synthesis</subject><subject>Schiff Bases - chemistry</subject><subject>Schiff Bases - pharmacology</subject><subject>Serum Albumin, Bovine - chemistry</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1v1DAQtRCILoV_gJCPHEhqO4kTc0DaLp9SBYfC2ZrYk61XSRzs7Kr7I_jPddi2x56eZvzePM88Qt5ylnPG5cUux92A5iYXqcqZyFlVPSMrXssmK0RVPicrJkSRVaIoz8irGHeMsUoy9pKcCalUKZVYkX8bP00YqPHD1OMtRtpCREv9SM2NC9DT64Rdly1t2rstjDZ-pJ9_ri8ur9e0daN145ZC63o3Hz8sD9T0CAfYIgUzu8P_tjnOfva3zqSKphF0-TmMLg7UdxQmP80-uviavOigj_jmHs_Jn69ffm--Z1e_vv3YrK8yU0gxZ4pVXKhKYo2qbpSyCA3UgI0obWfalisBCowQlpfAGptQKtk0PClEEhbn5P1p7hT83z3GWQ8uGux7GNHvo-Z1kyx4XdSJWp6oJvgYA3Z6Cm6AcNSc6SUIvdOnIPQShGZCpyCS7N29w74d0D6KHi6fCJ9OBEx7HhwGHY3D0aB1Ac2srXdPO9wB5mOcBA</recordid><startdate>20160523</startdate><enddate>20160523</enddate><creator>Zhou, Xue-Quan</creator><creator>Li, Yang</creator><creator>Zhang, Dong-Yan</creator><creator>Nie, Yan</creator><creator>Li, Zong-Jin</creator><creator>Gu, Wen</creator><creator>Liu, Xin</creator><creator>Tian, Jin-Lei</creator><creator>Yan, Shi-Ping</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160523</creationdate><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><author>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Anticancer ability</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis mechanism</topic><topic>Binding Sites - drug effects</topic><topic>Cattle</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Chirality</topic><topic>Copper - chemistry</topic><topic>Copper - pharmacology</topic><topic>Copper complexes</topic><topic>Crystal structure</topic><topic>Crystallography, X-Ray</topic><topic>DNA - chemistry</topic><topic>DNA Cleavage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Schiff Bases - chemical synthesis</topic><topic>Schiff Bases - chemistry</topic><topic>Schiff Bases - pharmacology</topic><topic>Serum Albumin, Bovine - chemistry</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xue-Quan</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Zhang, Dong-Yan</creatorcontrib><creatorcontrib>Nie, Yan</creatorcontrib><creatorcontrib>Li, Zong-Jin</creatorcontrib><creatorcontrib>Gu, Wen</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Tian, Jin-Lei</creatorcontrib><creatorcontrib>Yan, Shi-Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xue-Quan</au><au>Li, Yang</au><au>Zhang, Dong-Yan</au><au>Nie, Yan</au><au>Li, Zong-Jin</au><au>Gu, Wen</au><au>Liu, Xin</au><au>Tian, Jin-Lei</au><au>Yan, Shi-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2016-05-23</date><risdate>2016</risdate><volume>114</volume><spage>244</spage><epage>256</epage><pages>244-256</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively.
Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted]
•Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>26994692</pmid><doi>10.1016/j.ejmech.2016.02.055</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2016-05, Vol.114, p.244-256 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_1780511737 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Anticancer ability Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Apoptosis - drug effects Apoptosis mechanism Binding Sites - drug effects Cattle Cell Line, Tumor Cell Proliferation - drug effects Chirality Copper - chemistry Copper - pharmacology Copper complexes Crystal structure Crystallography, X-Ray DNA - chemistry DNA Cleavage Dose-Response Relationship, Drug Drug Screening Assays, Antitumor Humans Ligands Models, Molecular Molecular Structure Organometallic Compounds - chemical synthesis Organometallic Compounds - chemistry Organometallic Compounds - pharmacology Schiff Bases - chemical synthesis Schiff Bases - chemistry Schiff Bases - pharmacology Serum Albumin, Bovine - chemistry Structure-Activity Relationship |
title | Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A34%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper%20complexes%20based%20on%20chiral%20Schiff-base%20ligands:%20DNA/BSA%20binding%20ability,%20DNA%20cleavage%20activity,%20cytotoxicity%20and%20mechanism%20of%20apoptosis&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Zhou,%20Xue-Quan&rft.date=2016-05-23&rft.volume=114&rft.spage=244&rft.epage=256&rft.pages=244-256&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2016.02.055&rft_dat=%3Cproquest_cross%3E1780511737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780511737&rft_id=info:pmid/26994692&rft_els_id=S0223523416301453&rfr_iscdi=true |